Sorted By:

Relevance


ICYMI: New Report on Benefits of Cancer Medicines That Emerge After FDA Approval

PhRMA  |  Blog Post

”  Check out the full report here.
http://catalyst.phrma.org/icymi-new-report-on-benefits-of-cancer-medicines-that-emerge-after-fda-approval

New PhRMA report: New medicines in development for autoimmune diseases offer patients hope for brighter futures

PhRMA  |  Blog Post

View the full report here.
http://catalyst.phrma.org/new-phrma-report-new-medicines-in-development-for-autoimmune-diseases-offer-patients-hope-for-brighter-futures

Medicare Monday: A refresh on private negotiation in Part D

PhRMA  |  Blog Post

The New York Times reported that “if you talk to experts who study the pharmaceutical market in the United States, they aren’t optimistic that, by itself, letting the government play drug negotiator would take a big bite out of prescription drug spending.”
http://catalyst.phrma.org/medicare-monday-a-refresh-on-private-negotiation-in-part-d

PhRMA and Lupus Foundation of America Report More Than 300 Medicines in Development for Autoimmune Diseases

PhRMA  |  Press Release

View "Medicines in Development for Autoimmune Diseases" here.
https://www.phrma.org

340B Spotlight: New pieces of legislation continue momentum to fix 340B program

PhRMA  |  Blog Post

By freezing the new addition of some 340B entities, the bills would give Congress and the Health Resources and Services Administration an opportunity to thoroughly review the program to determine whether it is meeting its original intent – and there is a lot of evidence out there that 340B isn’t. 
http://catalyst.phrma.org/340b-spotlight-new-pieces-of-legislation-continue-momentum-to-fix-340b-program

Statement on Global IP Agenda: 2009 Special 301 Report

PhRMA  |  Press Release

“In addition, we applaud the Government’s recognition of progress made by Korea in IPR protection, which resulted in removing Korea from all lists in the present report.
https://www.phrma.org/press-release/phrma-statement-on-global-intellectual-property-agenda-2009-special-301-report

PhRMA Urges USTR to Protect American Innovators Abroad

PhRMA  |  Blog Post

To invest the substantial resources necessary over many years to develop and deliver new treatments and cures, America’s biopharmaceutical innovators and the more than 850,000 women and men they employ across the country depend on open markets and strong protection and enforcement of patents and regulatory test data at home and abroad.
http://catalyst.phrma.org/phrma-urges-ustr-to-protect-american-innovators-abroad

Clinical Trials Awareness Week Toolkit

PhRMA  |  Report

Also, many participants report great satisfaction in playing a key role in advancing medical science and helping scientists find new treatments that will help more people live longer, healthier lives.
https://www.phrma.org/report/clinical-trials-awareness-week-toolkit

GAO Report Finds Drug Prices Increasing at Lower Rate than Medical Inflation

PhRMA  |  Blog Post

Reports that focus only on brand-name medicines exaggerate drug price trends and miss the point that lower-priced, broadly used generics are possible only because they originated as a brand-name medicine.
http://catalyst.phrma.org/gao-report-finds-drug-prices-increasing-at-lower-rate-than-medical-inflation

New PhRMA and Epilepsy Foundation Report: 420 Medicines in Development for Neurological Disorders

PhRMA  |  Blog Post

Get Medicines in Development reports and other issue updates here.
http://catalyst.phrma.org/new-phrma-and-epilepsy-foundation-report-420-medicines-in-development-for-neurological-disorders

New PhRMA Report: Medicines in development offer hope for osteoporosis patients and families

PhRMA  |  Blog Post

  View the full report here: http://phrma.org/sites/default/files/pdf/medicines-in-development-report-osteoporosis.pdf
http://catalyst.phrma.org/new-phrma-report-medicines-in-development-offer-hope-for-osteoporosis-patients-and-families

Panel Discussion and New Report Highlight Benefit of Vermont Clinical Trials for Patients, State Economy

PhRMA  |  Press Release

"Greater awareness and understanding about clinical trials would allow them to explore participating in the research, and the new report provides a helpful step for getting more information about Vermont’s active trials." 
https://www.phrma.org/press-release/panel-discussion-and-new-report-highlight-benefit-of-vermont-clinical-trials-for-patients-state-economy

New Report Reveals Growth Trajectories and Top Policy Factors Affecting Biopharmaceutical Innovation & Growth

PhRMA  |  Press Release

More information about the report can be found here.
https://www.phrma.org/press-release/new-report-reveals-growth-trajectories-and-top-policy-factors-affecting-biopharmaceutical-innovation-and-growth

New Report Shows Over 3,200 Clinical Trials of Medicines Conducted by Indiana Research Institutions Since 1999

PhRMA  |  Press Release

The report highlights how clinical trials are addressing the serious challenges of chronic disease: In 2011, more than 10 percent of the state’s adults had diabetes, according to the state Department of Health.
https://www.phrma.org/press-release/new-report-shows-over-3-200-clinical-trials-of-medicines-conducted-by-indiana-research-institutions-since-1999

Value-Based Contracting for Oncology Drugs: A NEHI White Paper

PhRMA  |  Report

While new partnerships are developing between insurers and biopharmaceutical companies to increase patients’ access to medicines, outdated regulations prevent insurers from negotiating deals that lower the price of medicines when they are used in combinations or when they don’t deliver the promis...
https://www.phrma.org/report/value-based-contracting-for-oncology-drugs-a-nehi-white-paper

New Report Shows Record Number of Medicines Currently in Development to Treat Diabetes

PhRMA  |  Press Release

Of the medicines listed in the report, 36 have been or will be part of clinical trials conducted in West Virginia.
https://www.phrma.org/press-release/new-report-shows-record-number-of-medicines-currently-in-development-to-treat-diabetes

New report celebrates a decade of progress in chronic diseases

PhRMA  |  Blog Post

Read the report here: http://phrma.org/decade-of-innovation
http://catalyst.phrma.org/new-report-celebrates-a-decade-of-progress-in-chronic-diseases

New Report: Part B proposal is more aggressive than previous efforts

PhRMA  |  Blog Post

Last week, a new report released by Avalere Health took a closer look at the evolution of CMMI since its creation.
http://catalyst.phrma.org/new-report-part-b-proposal-is-more-aggressive-than-previous-efforts

New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS

PhRMA  |  Press Release

The report found that the 97 products in development include 23 vaccines and 54 antivirals.
https://www.phrma.org/press-release/new-report-shows-97-medicines-and-vaccines-currently-in-development-for-hiv/aids

New Report: Past Drug Failures Help Create the War on Cancer’s Next Successes

PhRMA  |  Press Release

View the full “Researching Cancer Medicines: Setbacks and Stepping Stones” report
https://www.phrma.org/press-release/new-report-past-drug-failures-help-create-the-war-on-cancer-s-next-successes

New Report Shows Record Number of Medicines Currently in Development to Treat Mental Illness

PhRMA  |  Press Release

Read the 2010 Medicines in Development for Mental Illness Report here. 
https://www.phrma.org/press-release/new-report-shows-record-number-of-medicines-currently-in-development-to-treat-mental-illness

New PhRMA Report: Nearly 200 medicines in development for heart disease, stroke and other cardiovascular diseases

PhRMA  |  Blog Post

View the full report here: Medicines in Development for Cardiovascular Diseases View the medicine list here: Heart Disease, Stroke Drug List
http://catalyst.phrma.org/new-phrma-report-medicines-in-development-for-heart-disease-stroke-2015

Medicines in Development for Heart Disease & Stroke 2015

PhRMA  |  Report

According to the American Heart Association, someone in the United States dies from cardiovascular disease every 40 seconds, and more than 85 million Americans have at least one form of the disease. Heart disease has been the leading cause of death in the United States since 1921, but these numbe...
https://www.phrma.org/report/medicines-in-development-for-heart-disease-and-stroke-2015-report

New Report Shows Colorado Clinical Trials Benefit State’s Health and Economy

PhRMA  |  Press Release

The appendix of the report provides information on each of the tests still recruiting patients because for some disease sufferers, the trials could be viable new therapeutic options to discuss with their health care providers. 
https://www.phrma.org/press-release/new-report-shows-colorado-clinical-trials-benefit-state-s-health-and-economy

RxOpen Activated to Report on Status of Pharmacies in Oklahoma

PhRMA  |  Press Release

With forecasts still calling for dangerous weather across this region of the country, Rx Response will continue to carefully monitor the impact of severe weather on the bio-pharmaceutical supply chain and report the status of area pharmacies at RxOpen.org.
https://www.phrma.org/press-release/rxopen-activated-to-report-on-status-of-pharmacies-in-oklahoma

You have reviewed the first 175 results out of 1012. Each page contains 25 results. You're on page 7.

prev 7 8 9 10 11 12 next